Skip to main content
SLU publication database (SLUpub)

Research article2008Peer reviewedOpen access

Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis

Piliponsky Adrian M., Chen Ching-Cheng, Nishimura Toshihiko, Metz Martin, Rios Eon J., Dobner Paul R., Wada Etsuko, Wada Keiji, Zacharias Sherma, Mohanasundaram Uma M., Faix James D., Abrink Magnus, Pejler Gunnar, Pearl Ronald G., Tsai Mindy, Galli Stephen J.

Abstract

Sepsis is a complex, incompletely understood and often fatal disorder, typically accompanied by hypotension, that is considered to represent a dysregulated host response to infection. Neurotensin (NT) is a 13-amino-acid peptide that, among its multiple effects, induces hypotension. We find that intraperitoneal and plasma concentrations of NT are increased in mice after severe cecal ligation and puncture (CLP), a model of sepsis, and that mice treated with a pharmacological antagonist of NT, or NT-deficient mice, show reduced mortality during severe CLP. In mice, mast cells can degrade NT and reduce NT-induced hypotension and CLP-associated mortality, and optimal expression of these effects requires mast cell expression of neurotensin receptor 1 and neurolysin. These findings show that NT contributes to sepsis-related mortality in mice during severe CLP and that mast cells can lower NT concentrations, and suggest that mast cell-dependent reduction in NT levels contributes to the ability of mast cells to enhance survival after CLP.

Published in

Nature Medicine
2008, Volume: 14, number: 4, pages: 392-398

      UKÄ Subject classification

      Animal and Dairy Science
      Veterinary Science

      Publication identifier

      DOI: https://doi.org/10.1038/nm1738

      Permanent link to this page (URI)

      https://res.slu.se/id/publ/20807